$IVDN Balance Sheet | Understand Stock

$IVDN

$0.25 -$0.01 (3.62%) Close

$IVDN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Jul 31, 2026	Q2 FY2026 As of Apr 30, 2026	Q1 FY2026 As of Jan 31, 2026	Q4 FY2025 As of Oct 31, 2025	Q3 FY2025 As of Jul 31, 2025	Q2 FY2025 As of Apr 30, 2025	Q1 FY2025 As of Jan 31, 2025	Q4 FY2024 As of Oct 31, 2024	Q3 FY2024 As of Jul 31, 2024	Q2 FY2024 As of Apr 30, 2024	Q1 FY2024 As of Jan 31, 2024	Q4 FY2023 As of Oct 31, 2023	Q3 FY2023 As of Jul 31, 2023	Q2 FY2023 As of Apr 30, 2023	Q1 FY2023 As of Jan 31, 2023	Q4 FY2022 As of Oct 31, 2022	Q3 FY2022 As of Jul 31, 2022	Q2 FY2022 As of Apr 30, 2022	Q1 FY2022 As of Jan 31, 2022	Q4 FY2021 As of Oct 31, 2021
Assets
Current assets
Cash
Cash and Cash Equivalents
Accounts Receivable, Net
Prepaid Expenses
Inventory, Net
Current portion of right of use asset
Receivable due
Prepaid rent
Other Current Receivables
Other Current Assets

Total current assets
Property, Plant, and Equipment, Net
Inventory on consignment
Advane to Employees
Advance to employees
Right of use asset, net of current portion
Deposits on Inventory
Deposits on Equipment
Other Long-Term Assets
Total Long-Term Assets
Total assets

Liabilities and Stockholders’ Deficit
Current liabilities
Credit Cards
Accounts Payable
Current portion of lease liability
Current portion of notes payable
Other current Liabilities

Total current liabilities
Lease liability, net of current portion
Notes Payable
Long-term portion of note payable
Long-term portion of shareholder’s loans
Long-term portion of stockholder loans
Reserve for unpaid debt
Operating lease liability
Due to stockholders
Shareholder’s loans
Accrued expenses
Long-Term Shareholder Loans
Total Long-Term Liabilities
Total liabilities

Stockholders’ deficit
Preferred stock, par value $0.0001; 25,000,000 shares authorized
Common stock, $0.0001 par value; 100,000,000 shares authorized; 38,504,003 and 38,504,003 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively
Common stock to be issued
Additional paid-in capital
Accumulated deficit
Net Income (Loss)
Total stockholders’ deficit
Total Stockholders’ equity
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Comments